Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study
CONCLUSIONS: Further actions to reduce fatigue and improve quality of life during neoadjuvant chemotherapy of early breast cancer are needed. Focus should be laid on the physical dimension. Future research should also investigate the impact of different chemotherapy sequences and densities on fatigue and quality of life.STUDY REGISTRATION: The study was registered in the German Clinical Trials Register in May 2019 (DRKS00016761).PMID:37966690 | DOI:10.1007/s12282-023-01520-y
Source: Breast Cancer - Category: Cancer & Oncology Authors: Florian Pelzer Wilfried Tr öger Marcus Reif Susanne Sch önberg David D Martin Cornelia M üller Isabell Utz-Billing Thorsten K ühn Stephan Baumgartner Marion Kiechle Daniela Paepke Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Clinical Trials | Germany Health | Men | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study